MidCap Financial is a middle market-focused, specialty finance firm that provides senior debt solutions to companies across all industries.
Business Model: B2B
Revenue: $75M
Employees: 201-500
Address: 7255 Woodmont Avenue
City: Bethesda
State: MD
Zip: 20814
Country: US
MidCap Financial is a middle market-focused, specialty finance firm that provides senior debt solutions to companies across all industries. We provide a broad array of products intended to finance growth and manage working capital. As of January 2015, MidCap Financial has over $3 billion of commitments under management. Since our founding in 2008, we have been working with management teams and sponsors to deliver thoughtful and cost effective debt solutions. Companies need a lender that understands their business and has the creativity and flexibility to provide financing solutions that are suited to their needs. At MidCap Financial, our years of experience, strong balance sheet, and flexibility make us the lender of choice for companies across all stages of growth and complexity. MidCap Financial is managed by Apollo Capital Management, L.P., a subsidiary of Apollo Global Management, LLC, pursuant to an investment management agreement. Apollo Global Management is one of the world&s;s largest asset managers with over $160B of assets under management (as of January 2015), providing market leading industry expertise, market reach, and financing synergies.
Contact Phone:
+13017607600
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2018 | Kashable | Debt Financing | 100M |
7/2017 | Sarepta Therapeutics | Post-IPO Debt | 100M |
4/2015 | Staffing 360 Solutions | Post-IPO Debt | 28M |
11/2022 | ViewRay | Post-IPO Debt | 125M |
8/2015 | Flexion Therapeutics | Post-IPO Debt | 30M |
12/2013 | Apollo Endosurgery | Debt Financing | 50M |
9/2014 | Aventine Renewable Energy Holdings Inc | Debt Financing | 40M |
5/2016 | Intarcia Therapeutics | Debt Financing | 75M |
10/2022 | Carbon6 Technologies | Debt Financing | - |
12/2013 | Amicus Therapeutics | Post-IPO Debt | 10M |
4/2014 | Larimar Therapeutics | Debt Financing | 20M |
1/2022 | Forge Biologics | Debt Financing | 0 |
11/2021 | Upstack | Private Equity Round | 100M |
5/2021 | Xtant Medical | Post-IPO Debt | 20M |
2/2019 | BioCryst Pharmaceuticals | Post-IPO Debt | 100M |
3/2021 | LendingPoint | Debt | 110M |
1/2018 | DNAnexus | Series E | 58M |
8/2015 | Quotient Biodiagnostics | Post-IPO Debt | 35M |
6/2017 | Aziyo Biologics | Venture Round | 12M |
6/2015 | BioDelivery Sciences | Post-IPO Debt | 20.7M |
3/2019 | Organogenesis | Debt Financing | 100M |
10/2016 | Oxford Immunotec | Post-IPO Debt | 40M |
10/2022 | Carbon6 | Series A | 0 |
5/2019 | Gossamer Bio | Post-IPO Debt | 150M |
3/2017 | Fundation | Debt Financing | 35M |
3/2014 | Omeros | Post-IPO Debt | 32M |
10/2022 | Surmodics | Post-IPO Debt | 125M |
5/2012 | Stellar Pharmaceuticals Inc | Debt Financing | 6M |
4/2018 | The Credit Junction | Debt Financing | 150M |
8/2010 | Endocyte | Venture Round | 15M |
5/2020 | Medexus Pharma | Post-IPO Debt | 0 |
12/2013 | Quotient Biodiagnostics | Debt Financing | 15M |
2/2018 | Partner Therapeutics | Series A | 60M |
9/2019 | Sight Sciences | Series D | 31M |
12/2015 | Spectranetics | Post-IPO Debt | 110M |
1/2020 | Digital Reasoning | Series D | 0 |
12/2019 | Arboretum Investment Advisors, LLC. | Debt Financing | 25M |
12/2021 | Aterian | Post-IPO Debt | 50M |
4/2016 | IOU Financial | Post-IPO Debt | 50M |
3/2013 | Theraclone Sciences | Debt Financing | 6M |
5/2022 | TELA Bio | Post-IPO Debt | 50M |
10/2019 | Protagonist Therapeutics | Post-IPO Debt | 50M |
2/2018 | ZPower | Debt Financing | 25M |
12/2018 | Sonar Entertainment | Debt Financing | 121M |
3/2016 | Spectra7 Microsystems | Post-IPO Debt | 6.5M |
9/2016 | BioCryst Pharmaceuticals | Post-IPO Debt | 23M |
8/2021 | Unchained Labs | Debt Financing | 0 |
5/2022 | TELA Bio | Post-IPO Debt | 0 |
1/2022 | Forge Biologics | Debt Financing | 0 |
12/2021 | Aterian | Post-IPO Debt | 0 |
11/2021 | Upstack | Debt Financing | 0 |
8/2021 | Unchained Labs | Debt Financing | 0 |
5/2021 | Xtant Medical | Post-IPO Debt | 0 |
3/2021 | LendingPoint | Debt Financing | 0 |
5/2020 | Medexus Pharma | Post-IPO Debt | 0 |
1/2020 | Digital Reasoning | Series D | 0 |
12/2019 | Arboretum Investment Advisors, LLC. | Debt Financing | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|